Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus

Antiphospholipid antibodies (aPL), especially lupus anticoagulant (LAC), characterize systemic lupus erythematosus (SLE) patients at increased risk for arterial and venous thromboembolic complications. It has been reported that purified human anti-phospholipid antibodies cause endothelial cell activ...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Frijns, C J M, Derksen, R H W M, De Groot, PH G, Algra, A, Fijnheer, R
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2001
Soggetti:
Rheumatic Disease/Vasculitis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1906104/
https://ncbi.nlm.nih.gov/pubmed/11472438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2249.2001.01520.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi